Description:6-Bromo-2,4-dichloroquinazoline is a heterocyclic organic compound characterized by its quinazoline structure, which consists of a fused benzene and pyrimidine ring. The presence of bromine and chlorine substituents at specific positions (6-bromo and 2,4-dichloro) contributes to its unique chemical properties and reactivity. This compound typically appears as a solid and is often used in pharmaceutical research and development due to its potential biological activity. It may exhibit properties such as antimicrobial, anti-inflammatory, or anticancer activities, making it of interest in medicinal chemistry. The presence of halogens can also influence its solubility, stability, and interaction with biological targets. As with many halogenated compounds, care must be taken regarding environmental and health impacts, as halogens can affect toxicity and bioaccumulation. Overall, 6-Bromo-2,4-dichloroquinazoline serves as a valuable scaffold in the synthesis of various derivatives for further exploration in drug discovery.
6-Bromo-2,4-dichloroquinazoline is a palladium-catalyzed cross-coupling reaction that produces a variety of functionalized quinazolinones. The reactants …
We use cookies to enhance your visit. We do not include advertising.
Please see our Cookies Policy for more details or adjust your preferences in "Settings".
This is the advanced settings system for our own and third-party cookies. Here you can modify parameters that will directly affect your browsing experience on this website. If you wish you may check the list of Cookie types.
Please note that disabling cookies can cause failures in the normal operation of the web.
